BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38100380)

  • 1. Isolation and
    Wanas AS; Radwan MM; Marzouk AA; Elkaeed EB; Alsfouk BA; Mostafa AE; Eissa IH; Metwaly AM; ElSohly MA
    Nat Prod Res; 2023 Dec; ():1-14. PubMed ID: 38100380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and In Silico Anti-SARS-CoV-2 Papain-Like Protease Potentialities of Two Rare 2-Phenoxychromone Derivatives from
    Suleimen YM; Jose RA; Suleimen RN; Arenz C; Ishmuratova M; Toppet S; Dehaen W; Alsfouk AA; Elkaeed EB; Eissa IH; Metwaly AM
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209006
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Rudrapal M; Issahaku AR; Agoni C; Bendale AR; Nagar A; Soliman MES; Lokwani D
    J Biomol Struct Dyn; 2022; 40(20):10437-10453. PubMed ID: 34182889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosynthesis of cannflavins A and B from Cannabis sativa L.
    Rea KA; Casaretto JA; Al-Abdul-Wahid MS; Sukumaran A; Geddes-McAlister J; Rothstein SJ; Akhtar TA
    Phytochemistry; 2019 Aug; 164():162-171. PubMed ID: 31151063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Discovery of Potential SARS-CoV-2 Natural Inhibitors among 4924 African Metabolites Targeting the Papain-like Protease: A Multi-Phase In Silico Approach.
    Elkaeed EB; Khalifa MM; Alsfouk BA; Alsfouk AA; El-Attar AMM; Eissa IH; Metwaly AM
    Metabolites; 2022 Nov; 12(11):. PubMed ID: 36422263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of Iminosugars as Antiviral Agents against SARS-CoV-2 Main Protease: Inhibitor Design and Optimization, Molecular Docking, and Molecular Dynamics Studies to Explore Potential Inhibitory Effect of 1-Deoxynojirmycin Series.
    Miglani V; Sharma P; Kumar Narula A
    Curr Comput Aided Drug Des; 2023 Aug; ():. PubMed ID: 37612857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannflavins - From plant to patient: A scoping review.
    Erridge S; Mangal N; Salazar O; Pacchetti B; Sodergren MH
    Fitoterapia; 2020 Oct; 146():104712. PubMed ID: 32858172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of
    Altyar AE; Youssef FS; Kurdi MM; Bifari RJ; Ashour ML
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566148
    [No Abstract]   [Full Text] [Related]  

  • 9. In Silico Screening of Some Active Phytochemicals to Identify Promising Inhibitors Against SARS-CoV-2 Targets.
    Alagarsamy V; Solomon VR; Murugesan S; Sundar PS; Muzaffar-Ur-Rehman MD; Chandu A; Aishwarya AD; Narendhar B; Sulthana MT; Ravikumar V
    Curr Drug Discov Technol; 2023 Oct; ():. PubMed ID: 37861016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Inhibitors from Nigella Sativa.
    Baig A; Srinivasan H
    Appl Biochem Biotechnol; 2022 Mar; 194(3):1051-1090. PubMed ID: 35102539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Potential SARS-CoV-2 Papain-like Protease Natural Inhibitors Employing a Multi-Phase In Silico Approach.
    Elkaeed EB; Metwaly AM; Alesawy MS; Saleh AM; Alsfouk AA; Eissa IH
    Life (Basel); 2022 Sep; 12(9):. PubMed ID: 36143445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and In Silico Inhibitory Potential against SARS-CoV-2 RNA Polymerase of the Rare Kaempferol 3-
    Suleimen YM; Jose RA; Mamytbekova GK; Suleimen RN; Ishmuratova MY; Dehaen W; Alsfouk BA; Elkaeed EB; Eissa IH; Metwaly AM
    Plants (Basel); 2022 Aug; 11(15):. PubMed ID: 35956550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual screening of phytoconstituents from miracle herb
    Siddiqui S; Upadhyay S; Ahmad R; Gupta A; Srivastava A; Trivedi A; Husain I; Ahmad B; Ahamed M; Khan MA
    J Biomol Struct Dyn; 2022 Jun; 40(9):3928-3948. PubMed ID: 33289456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors.
    Li D; Luan J; Zhang L
    Biochem Biophys Res Commun; 2021 Jan; 538():72-79. PubMed ID: 33276953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing an Analogue Based In Silico Pipeline in the Pursuit of Novel Inhibitory Scaffolds against the SARS Coronavirus 2 Papain-Like Protease.
    Hajbabaie R; Harper MT; Rahman T
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33672721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 proteases Mpro and PLpro: Design of inhibitors with predicted high potency and low mammalian toxicity using artificial neural networks, ligand-protein docking, molecular dynamics simulations, and ADMET calculations.
    Tumskiy RS; Tumskaia AV; Klochkova IN; Richardson RJ
    Comput Biol Med; 2023 Feb; 153():106449. PubMed ID: 36586228
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Huynh T; Cornell W; Luan B
    Front Chem; 2020; 8():624163. PubMed ID: 33614597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Computational Preventive Potential of the Rare Flavonoid, Patuletin, Isolated from
    Metwaly AM; Elkaeed EB; Alsfouk BA; Saleh AM; Mostafa AE; Eissa IH
    Plants (Basel); 2022 Jul; 11(14):. PubMed ID: 35890520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of structural scaffold from interbioscreen (IBS) database to inhibit 3CLpro, PLpro, and RdRp of SARS-CoV-2 using molecular docking and dynamic simulation studies.
    Patil VR; Dhote AM; Patil R; Amnerkar ND; Lokwani DK; Ugale VG; Charbe NB; Firke SD; Chaudhari P; Shah SK; Mehta CH; Nayak UY; Khadse SC
    J Biomol Struct Dyn; 2023; 41(22):13168-13179. PubMed ID: 36757134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitor induced conformational changes in SARS-COV-2 papain-like protease.
    Ferreira GM; Pillaiyar T; Hirata MH; Poso A; Kronenberger T
    Sci Rep; 2022 Jul; 12(1):11585. PubMed ID: 35803957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.